Friday, 13 Sep 2019

TNF inhibitor

Date Typesort ascending Title Save
13 Jul 2016 News FDA Arthritis Advisory Committee Recommends Approval of Adalimumab Biosimilar
05 Mar 2018 News Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept
17 May 2015 News Adalimumab Gets FDA Orphan Drug Status for Use in Hidradenitis Suppurativa
29 Mar 2019 News FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis
14 Sep 2015 News Adalimumab FDA Approved for Hidradenitis Suppurativa
17 May 2017 News Inflammatory Arthritis Stable after Switch to Biosimilar Infliximab
18 Jun 2015 News Frequency of Infliximab Infusion Reactions
22 Aug 2017 News It's Rheumatoid Arthritis, not the TNF inhibitor, that Drives Lymphoma Risk
17 Mar 2016 News TNF Inhibitors Increase Perioperative Infection Risk
28 Jun 2016 News Cancer Risk Lower with TNF inhibitors in Rheumatoid Arthritis
14 May 2015 News Hepatotoxicity and TNF Inhibitors
22 Feb 2019 News The Risk of Tuberculosis with TNF Inhibitors
02 Jan 2017 News Cautious Optimism for Biosimilars in Rheumatology
09 Feb 2016 News FDA Reviews Celltrion's Remicade Biosimilar Today
07 Dec 2017 News Infliximab Does Not Increase Perioperative Infection
18 Aug 2016 News Remicade Patent Infringements Denied: Opens Door for New Biosimilars
03 Aug 2018 News Higher Infection Rates for Infliximab in Psoriasis
05 Jun 2015 News Conventional DMARDs extend TNF inhibitor drug survival in patients with spondyloarthropathies
11 Feb 2019 ACR Video QD Clinic - Breast Cancer & a TNF Inhibitor
21 Nov 2017 ACR Video Dr. Rachel Tate: Sarcoidosis and TNF Inhibitors